Pharmaceuticals, Biotechnology and Life Sciences
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and…
Insights from community oncologists and practice staff uncover strategies to accelerate precision medicine, expand trial access and prepare for technology-driven…
WILMINGTON, Del.–(BUSINESS WIRE)–$INCY–Incyte (Nasdaq:INCY) announces the appointment of Richard Hoffman as Executive Vice President and General Counsel effective today, December…
WILMINGTON, Mass.–(BUSINESS WIRE)–Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the Evercore 8th Annual…
– New analyses from the ongoing open label extension (OLE) studies and findings from electroencephalogram (EEG) assessments in patients with…
First ever clinical evaluation of an in vivo HSC-directed gene insertion therapy aims to restore immune function for people living…
Iberdomide shows deep and sustained responses in newly diagnosed multiple myeloma First-in-class lymphoma CELMoD™ agent, golcadomide, delivers durable responses in…
Merck granted Fast Track Designation by the U.S. FDA for MK-2214 for the treatment of Alzheimer’s disease RAHWAY, N.J.–(BUSINESS WIRE)–Merck…
LUBLIN, Poland–(BUSINESS WIRE)–#HIVawareness–On the occasion of World AIDS Day 2025, AHF Poland reminds the public that the fight to end…
The company will showcase a wave of transformative innovations designed to address the most pressing challenges in healthcare, spanning the…